Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Consolidated Statements of Operations
Net sales	$ 194
Cost of sales	30,023
Operating Expenses
Selling, general and administrative expenses	138,270	$ 105,362	$ 31,316
Research and development expenses 1	107,816	284,016	70,967
Impairment of property plant & equipment and intangibles	111,389
Amortization of intangible assets		11,111
Total operating expenses	357,475	400,489	102,283
Loss from operations	(387,304)	(400,489)	(102,283)
Other income (expense)
Gain on sale of assets	100,906
Other income (expense)	788	(10,079)	(20,866)
Interest income (expense)	3,206	200	(901)
Loss before income taxes	(282,404)	(410,368)	(124,050)
Income tax expense	0	0	0
Net loss	(282,404)	(410,368)	(124,050)
Less preferred stock dividend	261
Net loss attributable to common shareholders	$ (282,665)	$ (410,368)	$ (124,050)
Net loss per share attributable to common shareholders
Basic (in dollars per share)	$ (1.35)	$ (2.27)	$ (1.28)
Diluted (in dollars per share)	$ (1.35)	$ (2.27)	$ (1.28)
Weighted-average number of common shares outstanding
Basic (in shares)	208,682	180,722	96,716
Diluted (in shares)	208,682	180,722	96,716